Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

47.13 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	8,666
Open	47.13
Bid (Size)	47.42 (1,000)
Ask (Size)	47.45 (100)
Prev. Close	47.13
Today's Range	47.13 - 47.13
52wk Range	43.32 - 55.73
Shares Outstanding	1,250,690,553
Dividend Yield	4.69%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth ↗

April 21, 2026

It will be a turbulent ride, but patient investors might come out of it much richer.

Via The Motley Fool

Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar

April 06, 2026

Shares of Soleno Therapeutics (NASDAQ: SLNO) surged more than 32% in early trading on Monday, April 6, 2026, following the blockbuster announcement that Neurocrine Biosciences (NASDAQ: NBIX) has...

Via MarketMinute

Performance

YTD	-2.3%	-2.3%
1 Month	+5.3%	+5.3%
3 Month	+3.0%	+3.0%
6 Month	-5.1%	-5.1%
1 Year	-7.5%	-7.5%

More News

The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports

April 06, 2026

Via MarketMinute

Sanofi ADR (NASDAQ:SNY) Presents a Classic Value Investment Case ↗

March 25, 2026

Via Chartmill

Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring

April 03, 2026

Via MarketMinute

Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution

March 31, 2026

Via MarketMinute

Sanofi (NASDAQ:SNY) Emerges as a Top Dividend Stock from Methodical Screening ↗

March 11, 2026

Via Chartmill

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

Via Finterra

Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly

March 27, 2026

Via MarketMinute

AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results

March 27, 2026

Via MarketMinute

Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data

March 26, 2026

Via MarketMinute

The Brain Barrier Broken: Inside Denali Therapeutics’ Landmark FDA Approval of AVLAYAH

March 26, 2026

Via Finterra

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

March 24, 2026

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗

March 20, 2026

Via The Motley Fool

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

March 16, 2026

Via MarketMinute

Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough

March 12, 2026

Via Finterra

DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch ↗

March 09, 2026

Via Stocktwits

The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology

March 06, 2026

Via Finterra

The Best Healthcare Stock to Invest $1,000 in Right Now ↗

March 02, 2026

Via The Motley Fool

The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines

February 27, 2026

Via Finterra

AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange

February 26, 2026

Via MarketMinute

European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO

February 23, 2026

Via MarketMinute

1 No-Brainer Biotech Stock To Buy Today and Never Sell ↗

February 21, 2026

Via The Motley Fool

Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline

February 17, 2026

Via Finterra

Sanofi Tightens Grip on Ocular Therapeutix with Revised Bid as Pivotal SOL-1 Trial Results Loom

February 16, 2026

Via MarketMinute

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?

Yes, Sanofi - American Depositary Shares is publicly traded.

What exchange does Sanofi - American Depositary Shares trade on?

Sanofi - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Sanofi - American Depositary Shares?

The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market

What is the current price of Sanofi - American Depositary Shares?

The current price of Sanofi - American Depositary Shares is 47.13

When was Sanofi - American Depositary Shares last traded?

The last trade of Sanofi - American Depositary Shares was at 04/21/26 04:00 PM ET

What is the market capitalization of Sanofi - American Depositary Shares?

The market capitalization of Sanofi - American Depositary Shares is 58.95B

How many shares of Sanofi - American Depositary Shares are outstanding?

Sanofi - American Depositary Shares has 59B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.